These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 38638079)

  • 1. Immunotherapy in Stage III-IV Colon Cancer: A Propensity Score-Matched Analysis of the National Cancer Database.
    Horesh N; Emile SH; Garoufalia Z; Gefen R; Zhou P; Nagarajan A; Wexner SD
    J Immunother; 2024 Apr; ():. PubMed ID: 38638079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotherapy in rectal cancer patients-a propensity score matched analysis of the National Cancer Database.
    Horesh N; Emile SH; Freund MR; Garoufalia Z; Gefen R; Nagarajan A; Wexner SD
    Int J Colorectal Dis; 2023 Dec; 39(1):8. PubMed ID: 38133666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Propensity-Score Matched Analysis of Survival Outcomes of Adjuvant Therapy in Stage II-III Signet-Ring Cell Carcinoma of the Colon.
    Emile SH; Horesh N; Garoufalia Z; Gefen R; Strassmann V; Wexner SD
    Clin Colorectal Cancer; 2024 Mar; 23(1):35-45. PubMed ID: 37980215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival benefit from immunocheckpoint inhibitors in stage IV non-small cell lung cancer patients with brain metastases: A National Cancer Database propensity-matched analysis.
    Takamori S; Komiya T; Powell E
    Cancer Med; 2021 Feb; 10(3):923-932. PubMed ID: 33340271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minimally invasive surgery for stage III colon adenocarcinoma is associated with less delay to initiation of adjuvant systemic therapy and improved survival.
    Lee L; Wong-Chong N; Kelly JJ; Nassif GJ; Albert MR; Monson JRT
    Surg Endosc; 2019 Feb; 33(2):460-470. PubMed ID: 29967992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is There a Role for Neoadjuvant Systemic Therapy for cT4bM0 Colon Cancer? A Propensity Score-Matched Analysis of the National Cancer Database.
    Kamel MK; Shchatsko A; Keane CA; Serpa E; Al-Qudah G; Rahouma M; Nituica C; Blebea J; Marar O
    Dis Colon Rectum; 2023 Nov; 66(11):1435-1448. PubMed ID: 36876973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of immunotherapy use in patients with stage IV pancreatic carcinoma.
    Guddati AK; Komiya T; Patel SJ; Sharma N; Powell E
    J Gastrointest Oncol; 2020 Aug; 11(4):654-662. PubMed ID: 32953149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of immunotherapy time-of-day infusion on overall survival among patients with advanced melanoma in the USA (MEMOIR): a propensity score-matched analysis of a single-centre, longitudinal study.
    Qian DC; Kleber T; Brammer B; Xu KM; Switchenko JM; Janopaul-Naylor JR; Zhong J; Yushak ML; Harvey RD; Paulos CM; Lawson DH; Khan MK; Kudchadkar RR; Buchwald ZS
    Lancet Oncol; 2021 Dec; 22(12):1777-1786. PubMed ID: 34780711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary tumor location and survival in colorectal cancer: A retrospective cohort study.
    Aggarwal H; Sheffield KM; Li L; Lenis D; Sorg R; Barzi A; Miksad R
    World J Gastrointest Oncol; 2020 Apr; 12(4):405-423. PubMed ID: 32368319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in Health Care Costs, Survival, and Time Toxicity in the Era of Immunotherapy and Targeted Systemic Therapy for Melanoma.
    Bateni SB; Nguyen P; Eskander A; Seung SJ; Mittmann N; Jalink M; Gupta A; Chan KKW; Look Hong NJ; Hanna TP
    JAMA Dermatol; 2023 Nov; 159(11):1195-1204. PubMed ID: 37672282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lower survival after right-sided versus left-sided colon cancers: Is an extended lymphadenectomy the answer?
    Lee L; Erkan A; Alhassan N; Kelly JJ; Nassif GJ; Albert MR; Rt Monson J
    Surg Oncol; 2018 Sep; 27(3):449-455. PubMed ID: 30217301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Propensity-score matched analysis of the pathologic outcomes and survival benefits of neoadjuvant therapy in stage II-III anal adenocarcinoma.
    Emile SH; Horesh N; Garoufalia Z; Gefen R; Zhou P; Wexner SD
    J Surg Oncol; 2023 Sep; 128(4):585-594. PubMed ID: 37183543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Better survival in right-sided versus left-sided stage I - III colon cancer patients.
    Warschkow R; Sulz MC; Marti L; Tarantino I; Schmied BM; Cerny T; Güller U
    BMC Cancer; 2016 Jul; 16():554. PubMed ID: 27464835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival outcomes for right-versus left-sided colon cancer and rectal cancer in England: A propensity-score matched population-based cohort study.
    Hodges N; Mackenzie H; D'Souza N; Brown G; Miskovic D
    Eur J Surg Oncol; 2022 Apr; 48(4):841-849. PubMed ID: 34688513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Liver Metastasis on First-Line Immunotherapy in Stage IV Non-Small Cell Lung Cancer.
    Komiya T; Takamori S; Shimokawa M
    World J Oncol; 2023 Aug; 14(4):234-245. PubMed ID: 37560341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutrophil-to-lymphocyte ratio is a prognostic factor for colon cancer: a propensity score analysis.
    Mazaki J; Katsumata K; Kasahara K; Tago T; Wada T; Kuwabara H; Enomoto M; Ishizaki T; Nagakawa Y; Tsuchida A
    BMC Cancer; 2020 Sep; 20(1):922. PubMed ID: 32977767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duration of chemotherapy prior to chemoradiation affects survival outcomes for resected stage I-II or unresected stage III pancreatic cancer.
    Ma SJ; Iovoli AJ; Hermann GM; Prezzano KM; Singh AK
    Cancer Med; 2019 Aug; 8(9):4110-4123. PubMed ID: 31183965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapy After Chemotherapy and Radiation for Clinical Stage III Lung Cancer.
    Pichert MD; Canavan ME; Maduka RC; Li AX; Ermer T; Zhan PL; Kaminski M; Udelsman BV; Blasberg JD; Park HS; Goldberg SB; Boffa DJ
    JAMA Netw Open; 2022 Aug; 5(8):e2224478. PubMed ID: 35925606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Propensity Score Matching Analysis of the Effect of Payer Status on the Survival of Colon Cancer Patients.
    Shi L; Suh W; Kavanaugh MM; Mills G; Thayer S; Shi R
    Cureus; 2021 Jun; 13(6):e15748. PubMed ID: 34285854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of 627 patients with right- and left-sided colon cancer in China: Differences in clinicopathology, recurrence, and survival.
    Qin Q; Yang L; Sun YK; Ying JM; Song Y; Zhang W; Wang JW; Zhou AP
    Chronic Dis Transl Med; 2017 Mar; 3(1):51-59. PubMed ID: 29063056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.